| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 7750% | ₹144 0% | 800 | ₹0.55 -45% | 19,375-10.71% |
| 00% | ₹126.7 0% | 820 | ₹0.85 -43.33% | 71,300-27.55% |
| 3,1000% | ₹84.15 0% | 840 | ₹1.35 -47.05% | 29,4508.57% |
| 2,3250% | ₹83.4 -32.74% | 850 | ₹1.55 -57.53% | 58,125-25% |
| 00% | ₹74.15 0% | 860 | ₹2.25 -50.54% | 42,625-14.06% |
| 7750% | ₹77.05 0% | 870 | ₹2.5 -56.52% | 35,6500% |
| 7750% | ₹76.15 0% | 880 | ₹3.15 -58.55% | 4,75,075-3.46% |
| 6,2000% | ₹68.3 0% | 890 | ₹4.5 -56.52% | 59,67571.11% |
| 69,75028.57% | ₹58.55 43.5% | 900 | ₹5 -60.93% | 2,56,525-11.96% |
| 22,47531.81% | ₹50 48.8% | 910 | ₹6.6 -60.94% | 52,700-10.52% |
| 94,550-41.90% | ₹43 56.64% | 920 | ₹8.55 -59.85% | 4,91,350-8.77% |
| 2,18,550-20.33% | ₹36.6 60.87% | 930 | ₹11.25 -55% | 1,63,52510.47% |
| 1,50,350-36.60% | ₹30 60.42% | 940 | ₹14.6 -57.61% | 1,83,67572.99% |
| 4,45,62520.79% | ₹24.25 60.59% | 950 | ₹18.7 -49.45% | 1,84,4509.17% |
| 2,11,575-1.08% | ₹19.8 60.97% | 960 | ₹23.75 -50.98% | 1,35,6250% |
| 1,51,1252.09% | ₹15.7 57% | 970 | ₹53.8 0% | 99,9750% |
| 1,48,025-11.16% | ₹12.25 50.3% | 980 | ₹36 -42.85% | 23,2500% |
| 94,5504.27% | ₹9.35 42.74% | 990 | ₹49.85 0% | 7750% |
| 4,86,700-13.25% | ₹7.3 31.53% | 1,000 | ₹71.75 -6.2% | 36,4250% |
| 37,2006.66% | ₹5.6 23.07% | 1,010 | ₹64.45 0% | 1,5500% |
| 2,52,65055.98% | ₹4.35 14.47% | 1,020 | - | - |
| 79,05052.23% | ₹3.75 15.38% | 1,030 | - | - |
| 8,90,475-6.12% | ₹2.95 3.5% | 1,040 | - | - |
| 50,375-62.64% | ₹2.05 -8.88% | 1,050 | ₹124 0% | 3,8750% |
| 67,425-6.45% | ₹1.6 -13.51% | 1,060 | ₹122.95 0% | 6,2000% |
| 58,125-9.63% | ₹0.7 -39.13% | 1,080 | - | - |
| 53,475-1.42% | ₹0.55 -45% | 1,100 | - | - |
| 17,050-24.13% | ₹0.4 -66.66% | 1,120 | ₹182.6 0% | 8,5250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
